encainide
This page covers all encainide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel protein type 5 subunit alpha.
Targets
Sodium channel protein type 5 subunit alpha
Marketed (1)
- ENCAINIDE · Cardiovascular
Patent intelligence
- encainide patent landscape — aggregated cliff calendar, attackable patents, originator estates